DrugCite
Search

PHENERGAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Phenergan Adverse Events Reported to the FDA Over Time

How are Phenergan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Phenergan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Phenergan is flagged as the suspect drug causing the adverse event.

Most Common Phenergan Adverse Events Reported to the FDA

What are the most common Phenergan adverse events reported to the FDA?

Completed Suicide
687 (2%)
Vomiting
485 (1.41%)
Nausea
448 (1.31%)
Overdose
441 (1.28%)
Drug Toxicity
409 (1.19%)
Drug Hypersensitivity
370 (1.08%)
Somnolence
359 (1.05%)
Cardiac Arrest
340 (.99%)
Dyspnoea
319 (.93%)
Drug Interaction
310 (.9%)
Respiratory Arrest
298 (.87%)
Show More Show More
Dizziness
281 (.82%)
Confusional State
265 (.77%)
Malaise
263 (.77%)
Headache
259 (.75%)
Pain
256 (.75%)
Death
250 (.73%)
Multiple Drug Overdose
249 (.73%)
Cardio-respiratory Arrest
237 (.69%)
Drug Ineffective
237 (.69%)
Loss Of Consciousness
221 (.64%)
Suicide Attempt
220 (.64%)
Depression
204 (.59%)
Multiple Drug Overdose Intentional
199 (.58%)
Pyrexia
198 (.58%)
Hypotension
193 (.56%)
Drug Exposure During Pregnancy
191 (.56%)
Diarrhoea
182 (.53%)
Abdominal Pain
179 (.52%)
Anxiety
171 (.5%)
Drug Abuse
171 (.5%)
Intentional Overdose
169 (.49%)
Constipation
168 (.49%)
Hallucination
163 (.47%)
Intentional Drug Misuse
163 (.47%)
Fatigue
162 (.47%)
Drug Dependence
158 (.46%)
Medication Error
157 (.46%)
Tremor
154 (.45%)
Fall
151 (.44%)
Insomnia
149 (.43%)
Back Pain
147 (.43%)
Asthenia
144 (.42%)
Convulsion
143 (.42%)
Hyperhidrosis
143 (.42%)
Hypersensitivity
139 (.4%)
Agitation
138 (.4%)
Dehydration
136 (.4%)
Poisoning
136 (.4%)
Hypertension
131 (.38%)
Pruritus
131 (.38%)
Depressed Level Of Consciousness
130 (.38%)
Feeling Abnormal
129 (.38%)
Lethargy
129 (.38%)
Heart Rate Increased
124 (.36%)
Alanine Aminotransferase Increased
121 (.35%)
Pain In Extremity
115 (.34%)
Syncope
115 (.34%)
Coma
114 (.33%)
Respiratory Depression
112 (.33%)
Tachycardia
112 (.33%)
Serotonin Syndrome
111 (.32%)
Aggression
110 (.32%)
Myalgia
110 (.32%)
Oedema Peripheral
109 (.32%)
Blood Pressure Increased
107 (.31%)
Pulmonary Oedema
106 (.31%)
Suicidal Ideation
106 (.31%)
Rash
105 (.31%)
Weight Decreased
105 (.31%)
Accidental Overdose
104 (.3%)
Chest Pain
104 (.3%)
Condition Aggravated
104 (.3%)
Cough
103 (.3%)
Decreased Appetite
100 (.29%)
Pneumonia
99 (.29%)
Metabolic Acidosis
94 (.27%)
Muscle Spasms
89 (.26%)
Unresponsive To Stimuli
89 (.26%)
Aspartate Aminotransferase Increase...
88 (.26%)
Renal Failure Acute
88 (.26%)
Mental Status Changes
87 (.25%)
Anaemia
83 (.24%)
Abdominal Pain Upper
81 (.24%)
Urinary Tract Infection
81 (.24%)
Cerebrovascular Accident
79 (.23%)
Atrial Fibrillation
78 (.23%)
Drug Administration Error
77 (.22%)
Erythema
77 (.22%)
Rhabdomyolysis
77 (.22%)
Urticaria
77 (.22%)
Weight Increased
77 (.22%)
Delirium
76 (.22%)
Paraesthesia
75 (.22%)
Renal Failure
74 (.22%)
Arthralgia
73 (.21%)
Bradycardia
73 (.21%)
Hypoaesthesia
72 (.21%)
Respiratory Failure
72 (.21%)
Blood Creatine Phosphokinase Increa...
71 (.21%)
Gait Disturbance
71 (.21%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Phenergan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Phenergan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Phenergan

What are the most common Phenergan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Phenergan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Phenergan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Phenergan According to Those Reporting Adverse Events

Why are people taking Phenergan, according to those reporting adverse events to the FDA?

Nausea
3011
Drug Use For Unknown Indication
2775
Pain
2124
Product Used For Unknown Indication
2068
Cough
750
Vomiting
546
Show More Show More
Back Pain
433
Migraine
296
Headache
213
Rheumatoid Arthritis
195
Arthralgia
191
Analgesic Therapy
172
Nasopharyngitis
124
Osteoarthritis
119
Premedication
119
Diarrhoea
115
Ill-defined Disorder
107
Arthritis
102
Nasal Congestion
90
Abdominal Pain
88
Preoperative Care
82
Musculoskeletal Pain
75
Hypersensitivity
74
Insomnia
72
Bronchitis
67
Schizophrenia
66
Suicide Attempt
65
Drug Exposure During Pregnancy
64
Crohns Disease
63
Anxiety
63
Hypotension
61
Pain In Extremity
60
Prophylaxis
56
Procedural Pain
55
Sleep Disorder
54
Mydriasis
54
Prophylaxis Of Nausea And Vomiting
54
Fibromyalgia
52
Cancer Pain
48
Analgesia
46
Intentional Overdose
46
Muscle Spasms
45
Neck Pain
45
Upper Respiratory Tract Infection
43
Cataract Operation
42
Sciatica
40
Foetal Exposure During Pregnancy
40
Toothache
38
Multiple Allergies
37
Depression
35
Pain Management
35

Drug Labels

LabelLabelerEffective
PhenerganBaxter Healthcare Corporation25-NOV-09
PhenerganWest-ward Pharmaceutical Corp.11-JUN-12
PhenerganWest-ward Pharmaceutical Corp.25-SEP-12

Phenergan Case Reports

What Phenergan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Phenergan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Phenergan.